×
Final Agenda Available

September 16 - 17

Target Identification and Validation – Part 1Target Identification and Validation – Part 1

NEW
RNA as a Drug TargetRNA as a Drug Target
PROTACs and Targeted Protein Degradation – Part 1PROTACs and Targeted Protein Degradation – Part 1
Lead and Candidate Selection for Therapeutic ProteinsLead and Candidate Selection for Therapeutic Proteins

NEW
Antibodies Against Membrane Protein Targets – Part 1Antibodies Against Membrane Protein Targets – Part 1
Small G ProteinsSmall G Proteins

NEW
Immunology and Oncology: Emerging Drug Targets and TherapeuticsImmunology and Oncology
Targeting NASHTargeting NASH
Disease Modeling

 NEW
CNS, Gene and Cell Therapy

 NEW

September 17 - 18

Target Identification and Validation – Part 2Target Identification and Validation – Part 2
Lead Generation StrategiesLead Generation Strategies
PROTACs and Targeted Protein Degradation – Part 2PROTACs and Targeted Protein Degradation – Part 2
Modality Selection for Next-Gen Biotherapeutics

NEW
Antibodies Against Membrane Protein Targets – Part 2Antibodies Against Membrane Protein Targets – Part 2
Kinase Inhibitor DiscoveryKinase Inhibitor Discovery
GPCR-Based Drug Discovery GPCR-Based Drug Discovery
Targeting Fibrosis
Preclinical Strategies, Models and Tools in OncologyPreclinical Strategies, Models and Tools in Oncology

 NEW
Clinical and Translational BiomarkersClinical and Translational Biomarkers

 NEW


William G. Kaelin, Jr., MD

2020 Plenary Keynote: Tackling Undruggable Oncoproteins: Lessons from the VHL Tumor Suppressor Protein

William G. Kaelin, Jr., MD

Professor and Investigator, Howard Hughes Medical Institute, Oncology, Dana-Farber Cancer Institute

A Nobel laureate, Dr. Kaelin received the 2019 Nobel Prize in Physiology or Medicine. Dr. Kaelin is a member of the American Society of Clinical Investigation, the American College of Physicians, the National Academy of Sciences and the National Academy of Medicine.


READ MORE


Our Commitment to Community

As the coronavirus situation further develops, the health and well-being of our community remains our top priority. We would never have dreamt our world would be facing such uncertain times. Our team has been working for months behind the scenes planning the 2020 event.

READ MORE



2019 Featured Speakers

John Doench, PhD
Broad Institute of Harvard and MIT

Bryan Fuchs, PhD
Ferring Research Institute

Nathanael S. Gray, PhD
Dana-Farber Cancer Institute

Stephen J. Haggarty, PhD
Harvard Medical School & Massachusetts General Hospital

Cory M. Hogaboam, PhD
Cedars-Sinai Medical Center

Paul A. Insel, MD
University of California, San Diego

Ian James, PhD
Trevena, Inc.

Elliott Nickbarg, PhD
Merck & Co, Inc.

Andrew Nixon, PhD
Boehringer Ingelheim

J. Brad Shotwell, PhD
AbbVie

Rebecca Taub, MD
Madrigal Pharmaceuticals

Peter M. Tessier, PhD
University of Michigan

Shaomeng Wang, PhD
University of Michigan

Kevin Weeks, PhD
University of North Carolina

Join the Discovery on Target Community

Discovery on Target (DOT) is the industry’s preeminent event on novel drug targets and technologies for drug discovery professionals. DOT highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents, ranging from biologics to small molecules.

We aim to meet your research needs. At DOT, you can travel across numerous concurrent sessions and customize your experience further through comprehensive training seminars, focused short courses, interactive roundtable discussions, and engaging networking functions.

Our 2020 event is expanding to 20 conference programs including new topics on proteomics, small G proteins, disease modeling, preclinical oncology models and tools, CNS, gene and cell therapy, and biomarkers, plus lead and candidate selection for therapeutic proteins and modality selection for next-generation biotherapeutics to continue our growing coverage of biologics.

Over 1,100 international peers will convene for our 18th annual event in the biotech hub that is Boston, MA on September 15-18, 2020. We welcome you to join our community and be part of our 2020 event!



Event at a Glance
Stats
Brochure Download
See Who's Attending


Premier Sponsors






#BostonDOT20

OutlookAdd to your Outlook Calendar

LinkedInJoin our LinkedIn Group

FacebookFollow us on Facebook

YouTubeWatch Event Coverage on YouTube

TwitterFollow Discovery on Target on Twitter